Physiogenex is a preclinical CRO providing original and benchmarked animal models of obesity/type 2 diabetes and related co-morbidities:
NASH, dyslipidemia, inflammation, fibrosis, diabetic nephropathy, neuropathy, HFpEF and atherosclerosis.
For 20 years, we have been evaluating the efficacy of its clients‘ drugs using gold-standard and radiotracer-based experiments in our validated preclinical models.
With a 97.5% customer satisfaction rate last year, our clients benefit from our experience in drug development and expertise in metabolic diseases, as demonstrated by our numerous co-publications with our industrial partners.
Staburo offers advanced, high-quality data science services and programming for international pharmaceutical, CRO and biotech clients.
We are experts in data science, with services including: biostatistics and programming, translational medicine and biomarkers, data transparency and bioinformatics.
Working with leading pharma companies, we know how to successfully bring compounds to the patient and are a reliable and flexible partner for our clients.
More information: https://staburo.com/
FGK Clinical Research is a full-service CRO offering the full range of clinical development and consulting services throughout Europe. FGK has two subsidiaries: „FGK Pharmacovigilance“ and „FGK Representative Services.“
These allow us to offer our clients pharmacovigilance services, including QPPV and PSMF management, as well as legal representation for non-European clients conducting clinical trials or seeking marketing authorization within the EU/EEA.